Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1973 4
1974 7
1975 2
1976 3
1978 3
1979 4
1980 1
1981 6
1982 14
1983 6
1984 13
1985 11
1986 9
1987 8
1988 14
1989 18
1990 11
1991 15
1992 12
1993 12
1994 9
1995 10
1996 10
1997 10
1998 3
1999 5
2000 2
2001 2
2002 4
2003 4
2004 3
2005 2
2006 1
2007 2
2008 5
2009 3
2010 5
2011 2
2012 6
2013 1
2014 5
2015 9
2016 2
2018 3
2019 3
2020 4
2021 3
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

289 results
Results by year
Filters applied: . Clear all
Page 1
BIOMARKERS AND NEUROBEHAVIORAL DIAGNOSIS.
Ewen JB, Potter WZ, Sweeney JA. Ewen JB, et al. Among authors: potter wz. Biomark Neuropsychiatry. 2021 Jun;4:100029. doi: 10.1016/j.bionps.2020.100029. Epub 2021 Jan 4. Biomark Neuropsychiatry. 2021. PMID: 34430906 Free PMC article.
Translating glutamate: from pathophysiology to treatment.
Javitt DC, Schoepp D, Kalivas PW, Volkow ND, Zarate C, Merchant K, Bear MF, Umbricht D, Hajos M, Potter WZ, Lee CM. Javitt DC, et al. Among authors: potter wz. Sci Transl Med. 2011 Sep 28;3(102):102mr2. doi: 10.1126/scitranslmed.3002804. Sci Transl Med. 2011. PMID: 21957170 Free PMC article. Review.
Revolutionizing Alzheimer's disease and clinical trials through biomarkers.
Mattsson N, Carrillo MC, Dean RA, Devous MD Sr, Nikolcheva T, Pesini P, Salter H, Potter WZ, Sperling RS, Bateman RJ, Bain LJ, Liu E. Mattsson N, et al. Among authors: potter wz. Alzheimers Dement (Amst). 2015 Oct 3;1(4):412-9. doi: 10.1016/j.dadm.2015.09.001. eCollection 2015 Dec. Alzheimers Dement (Amst). 2015. PMID: 27239522 Free PMC article. Review.
Discovering translational biomarkers in neurodevelopmental disorders.
Sahin M, Jones SR, Sweeney JA, Berry-Kravis E, Connors BW, Ewen JB, Hartman AL, Levin AR, Potter WZ, Mamounas LA. Sahin M, et al. Among authors: potter wz. Nat Rev Drug Discov. 2018 Dec 20:10.1038/d41573-018-00010-7. doi: 10.1038/d41573-018-00010-7. Online ahead of print. Nat Rev Drug Discov. 2018. PMID: 30936503 Free PMC article.
Metabolism of tricyclic antidepressants.
Rudorfer MV, Potter WZ. Rudorfer MV, et al. Among authors: potter wz. Cell Mol Neurobiol. 1999 Jun;19(3):373-409. doi: 10.1023/a:1006949816036. Cell Mol Neurobiol. 1999. PMID: 10319193 Review.
Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease.
Libiger O, Shaw LM, Watson MH, Nairn AC, Umaña KL, Biarnes MC, Canet-Avilés RM, Jack CR Jr, Breton YA, Cortes L, Chelsky D, Spellman DS, Baker SA, Raghavan N, Potter WZ; Alzheimer's Disease Neuroimaging Initiative (ADNI); Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium, Longitudinal CSF Proteomics Project Team. Libiger O, et al. Among authors: potter wz. Alzheimers Dement. 2021 Dec;17(12):1976-1987. doi: 10.1002/alz.12353. Epub 2021 May 13. Alzheimers Dement. 2021. PMID: 33984181 Free PMC article.
The pharmacologic treatment of depression.
Potter WZ, Rudorfer MV, Manji H. Potter WZ, et al. N Engl J Med. 1991 Aug 29;325(9):633-42. doi: 10.1056/NEJM199108293250907. N Engl J Med. 1991. PMID: 1861697 Review. No abstract available.
289 results